Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA‑1/ENGOT-ov25.
Montégut C, Falandry C, Cinieri S, Cropet C, Montane L, Rousseau F, Joly F, Moubarak M, Mosconi AM, Guerra-Alía EM, Schauer C, Fujiwara H, Vergote I, Parma G, Lindahl G, Anota A, Canzler U, Marmé F, Pujade-Lauraine E, Ray-Coquard I, Sabatier R. Montégut C, et al. Among authors: cinieri s. Oncologist. 2024 Dec 14:oyae322. doi: 10.1093/oncolo/oyae322. Online ahead of print. Oncologist. 2024. PMID: 39673779 Free article.
Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study.
Procopio G, Chiuri VE, Giordano M, Alitto AR, Maisano R, Bordonaro R, Cinieri S, Rossetti S, De Placido S, Airoldi M, Galli L, Gasparro D, Ludovico GM, Guglielmini PF, Carella C, Nova P, Aglietta M, Schips L, Beccaglia P, Sciarra A, Livi L, Santini D; ABItude Study Group. Procopio G, et al. Among authors: cinieri s. ESMO Open. 2022 Apr;7(2):100431. doi: 10.1016/j.esmoop.2022.100431. Epub 2022 Apr 8. ESMO Open. 2022. PMID: 35405438 Free PMC article.
Can Morphology and Immune Infiltration Predict the Homologous Recombination Deficiency Status in Newly Diagnosed High-Grade Serous Ovarian Carcinoma?
Kime A, Bataillon G, Treilleux I, Callens C, Selle F, Heitz F, Cinieri S, González-Martin A, Schauer C, Lindahl G, Parma G, Vergote I, Matsumoto T, Blonz C, Canzler U, Mosconi AM, Guerra Alía EM, Pujade-Lauraine E, Genestie C, Ray-Coquard I, Just PA. Kime A, et al. Among authors: cinieri s. Arch Pathol Lab Med. 2024 Dec 9. doi: 10.5858/arpa.2024-0081-OA. Online ahead of print. Arch Pathol Lab Med. 2024. PMID: 39648143 Free article.
Testing BRCA 1-2 Mutations in Metastatic Prostate Cancer: Results of a Survey of the Italian Association of Medical Oncology.
Saporita I, Calabrese M, Poletto S, Turco F, Di Stefano RF, Caffo O, Russo A, De Giorgi U, Tucci M, Di Maio M, Cinieri S, Buttigliero C. Saporita I, et al. Among authors: cinieri s. Clin Genitourin Cancer. 2024 Nov 1;23(1):102255. doi: 10.1016/j.clgc.2024.102255. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39615118
Harnessing tumor metabolism during cancer treatment: A narrative review of emerging dietary approaches.
Silvestris N, Aprile G, Tessitore D, Mentrasti G, Cristina Petrella M, Speranza D, Casirati A, Caccialanza R, Cinieri S, Pedrazzoli P; Italian Intersociety Working Group for Nutritional Support in Cancer Patients. Silvestris N, et al. Among authors: cinieri s. Crit Rev Oncol Hematol. 2024 Nov 22;206:104571. doi: 10.1016/j.critrevonc.2024.104571. Online ahead of print. Crit Rev Oncol Hematol. 2024. PMID: 39581244 Review.
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Harter P, Marth C, Mouret-Reynier MA, Cropet C, Lorusso D, Guerra-Alía EM, Matsumoto T, Vergote I, Colombo N, Mäenpää J, Lebreton C, de Gregorio N, Mosconi AM, Rubio-Pérez MJ, Bourgeois H, Fasching PA, Cecere SC, Hardy-Bessard AC, Denschlag D, de Percin S, Hanker L, Favier L, Bauerschlag D, Desauw C, Hillemanns P, Largillier R, Sehouli J, Grenier J, Pujade-Lauraine E, Ray-Coquard I; PAOLA-1/ENGOT-ov25 investigators. Harter P, et al. Ann Oncol. 2024 Nov 9:S0923-7534(24)04907-X. doi: 10.1016/j.annonc.2024.10.828. Online ahead of print. Ann Oncol. 2024. PMID: 39528049 Free article.
Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial.
Indraccolo S, Signoriello S, Piga I, Esposito G, Ferrarini F, Boscolo Bragadin A, Salutari V, Pisano C, Califano D, Bignotti E, Tognon G, Simeon V, Artioli G, Ferrero A, Cinieri S, Bologna A, Chiodini P, Scognamiglio G, Bottoni C, Spina A, Russo D, Arenare L, Perrone F, Pignata S. Indraccolo S, et al. Among authors: cinieri s. Int J Biol Markers. 2024 Dec;39(4):328-337. doi: 10.1177/03936155241296164. Epub 2024 Nov 8. Int J Biol Markers. 2024. PMID: 39513196 Free article.
Withdrawal notice to <Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912]>
Iacovino ML, Celant S, Tomassini L, Arenare L, Caglio A, Canciello A, Salerno F, Olimpieri PP, Di Segni S, Sferrazza A, Piccirillo MC, Beretta GD, Pinto C, Blasi L, Cinieri S, Cavanna L, Di Maio M, Russo P, Perrone F. Iacovino ML, et al. Among authors: cinieri s. Lancet Reg Health Eur. 2024 Sep 2;44:101012. doi: 10.1016/j.lanepe.2024.101012. eCollection 2024 Sep. Lancet Reg Health Eur. 2024. PMID: 39444700 Free PMC article.
Scientific Communication and oncology - "The bridge between knowledge and patients".
Galvano A, Gottardo A, Gristina V, Fanale D, Corsini LR, Pavone C, Bazan Russo TD, Di Giovanni E, Iannì G, Randazzo U, Iacono F, Perez A, Brando C, Bono M, Bazan V, Incorvaia L, Badalamenti G, Cinieri S, Boldrini M, Berardi R, Russo A. Galvano A, et al. Among authors: cinieri s. Crit Rev Oncol Hematol. 2024 Dec;204:104531. doi: 10.1016/j.critrevonc.2024.104531. Epub 2024 Oct 18. Crit Rev Oncol Hematol. 2024. PMID: 39427840 Free article. Review.
Radioligand therapy in the therapeutic strategy for patients with gastro-entero-pancreatic neuroendocrine tumors: a consensus statement from the Italian Association for Neuroendocrine Tumors (Itanet), Italian Association of Nuclear Medicine (AIMN), Italian Society of Endocrinology (SIE), Italian Association of Medical Oncology (AIOM).
Panzuto F, Albertelli M, De Rimini ML, Rizzo FM, Grana CM, Cives M, Faggiano A, Versari A, Tafuto S, Fazio N, Colao A, Scalorbi F, Ferone D, Cinieri S, Maccauro M. Panzuto F, et al. Among authors: cinieri s. J Endocrinol Invest. 2024 Oct 12. doi: 10.1007/s40618-024-02448-6. Online ahead of print. J Endocrinol Invest. 2024. PMID: 39395114 Review.
290 results